Jaenecke Frank, Nakada-Nakura Yoshiko, Nagarathinam Kumar, Ogasawara Satoshi, Liu Kehong, Hotta Yunhon, Iwata So, Nomura Norimichi, Tanabe Mikio
HALOmem, Membrane Protein Biochemistry, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
Methods Mol Biol. 2018;1700:97-109. doi: 10.1007/978-1-4939-7454-2_7.
A major hurdle in membrane protein crystallography is generating crystals diffracting sufficiently for structure determination. This is often attributed not only to the difficulty of obtaining functionally active protein in mg amounts but also to the intrinsic flexibility of its multiple conformations. The cocrystallization of membrane proteins with antibody fragments has been reported as an effective approach to improve the diffraction quality of membrane protein crystals by limiting the intrinsic flexibility. Isolating suitable antibody fragments recognizing a single conformation of a native membrane protein is not a straightforward task. However, by a systematic screening approach, the time to obtain suitable antibody fragments and consequently the chance of obtaining diffracting crystals can be reduced. In this chapter, we describe a protocol for the generation of Fab fragments recognizing the native conformation of a major facilitator superfamily (MFS)-type MDR transporter MdfA from Escherichia coli. We confirmed that the use of Fab fragments was efficient for stabilization of MdfA and improvement of its crystallization properties.
膜蛋白晶体学中的一个主要障碍是生成足以用于结构测定的衍射晶体。这通常不仅归因于获得毫克量功能活性蛋白的困难,还归因于其多种构象的固有灵活性。据报道,膜蛋白与抗体片段的共结晶是一种通过限制固有灵活性来提高膜蛋白晶体衍射质量的有效方法。分离识别天然膜蛋白单一构象的合适抗体片段并非易事。然而,通过系统筛选方法,可以减少获得合适抗体片段的时间,从而增加获得衍射晶体的机会。在本章中,我们描述了一种生成识别来自大肠杆菌的主要转运体超家族(MFS)型多药耐药转运蛋白MdfA天然构象的Fab片段的方案。我们证实,使用Fab片段对稳定MdfA和改善其结晶特性是有效的。